Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells

Journal of Drug Delivery Science and Technology

Volumn 15, Issue 3, 2005, Pages 201-206

  Bozdag S ^a   Capan Y ^a   Dalkara, T ^a   Dogan, A L ^a   Guc, D ^a   Hincal, A A ^a   Deluca, P P ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b University of Kentucky   (United States)

Author keywords

Biodegradable microsphere; Glioma; Mitoxantrone; MTT test

Indexed keywords

BOVINE SERUM ALBUMIN; CHITOSAN; MICROSPHERE; MITOXANTRONE; POLYGLACTIN;

ANIMAL CELL; ARTICLE; BIODEGRADABLE IMPLANT; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; EXTRACTION; GLIOMA CELL; IN VITRO STUDY; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT;

EID: 18444413512     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. EMERICH D.F., WINN S.R., HU Y., MARSH J., SNODGRASS P., LAFRENIERE D., WIENS T., HASLER B.P., BARTUS R.T. - Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. - Pharm. Res., 17, 767-775, 2000.
2. EMERICH D.F., WINN S.R., SNODGRASS P., LAFRENIERE D., AGOSTINO M., WIENS T., XIONG H., BARTUS R.T. - Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors. - Pharm. Res., 17, 776-781, 2000.
3. TAMARGO R.J., MYSEROS J.S., EPSTEIN J.I., JANG M.B., CHASIN M., BREM H. - Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery to the brain. - Cancer Res., 53, 329-333, 1993.
4. WALTER K.A., CAHAN M.A., GUR A., TYLER B., HILTON J., COLVIN M.O., BURGER P.C., DOMB A., BREM H. - Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. - Cancer Res., 54, 2207-2212, 1994.
5. LILLEHEI K.O., KONG Q., WITHROW S.J., KLEINSCHMIDT-DEMASTERS B. - Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat. - Neurosurgery, 39, 1191-1197, 1996.
6. MENEI P., BOISDRON-CELLE M., CROUE A., GUY G., BENOIT J.P. - Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma bearing rats. - Neurosurgery, 39, 117-124, 1996.
7. OLIVI A., EWEND M.G, UTSUKI T., TYLER B., DOMB A. J., BRAT D.J., BREM H. - Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. - Cancer Chemother. Pharmacol., 39, 90-96, 1996.
8. DIMECO F., LI K. W., TYLER B.M., WOLF A. S., BREM H., OLIVI A. - Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. - J. Neurosurg., 97, 1173-1178, 2002.
9. BREM H., EWEND M.G., PIANTADOSI S., GREEHOOT J., BURGER P.C., SISTI M. - The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. - J. Neuro-oncol., 26, 111-123, 1995.
10. BREM H., PIANTADOSI S., BURGER P.C., WALKER M., SELKER R., VICK N.A, BLACK K.L., SISTI M., BREM S., MOHR G., MULLER P., MORAWETS R., SCHOLD R. - Placebo-controlled trials of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. - Lancet, 345, 1008-1012, 1995.
11. WALTER K.A., TAMARGO R.J., OLIVI A., BURGER P.C., BREM H. - Intratumoral chemotherapy. - Neurosurgery, 37, 1129-1145, 1995.
12. RESZKA R., BECK P., FICHTNER I., HENTSCHEL M., RICHTER J., KREUTER J. - Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice. - J. Pharmacol. Exp. Ther., 280, 232-237, 1997.
13. EHNINGER G., SCHULER U., PROKSCH B., ZELLER K.P., BLANZ J. - Pharmacokinetics and metabolism of mitoxantrone, a review. - Clin. Pharmacokinet., 18, 365-380, 1990.
14. SENKAL M., TONN J.C., SCHONMAYR R., SCHACHENMAYR W., EICKHOFF U., KEMEN M., KOLLIG E. - Mitoxantrone induced DNA strand breaks in cell cultures of malignant human astrocytoma and glioblastoma tumors. - J. Neuro-Oncol., 32, 203-208, 1997.
15. MENEI P., VENIER M.C., GAMELIN E., SAINT-ANDRE J.P., HAYEK G., JADAUD E., FOURNIER D., MERCIER P., GUY G., BENOIT J.P. - Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for radiosensitization of glioblastoma. - Cancer, 86, 324-329, 1999.
16. BENOIT J.P., FAISANT N., VENIER-JULIENNE M.C., MENEI P. - Development of microspheres for neurological disorders: from basics to clinical applications. - J. Control. Rel., 65, 285-296, 2000.
17. HU O.Y.P., CHANG S.P., SONG Y.B., CHEN K.Y., LAW C.K. - Novel assay method for mitoxantrone in plasma, and its application in cancer patients. - J. Chromatography, 532, 337-350, 1990.
18. JAMEELA S.R., LATHA P.G., SUBRAMONIAM A., JAYAKRISHNAN A. - Anti-tumor activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. - J. Pharm. Pharmacol., 48, 685-688, 1996.
19. LONGO W.E., HIROO I., THOM A.L., GOLDBERG E.P. - Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. - J. Pharm. Sci., 71, 1323-1328, 1982.
20. BOZDAǦ S., ÇAPAN Y., VURAL İ., DALKARA T., DOGAN A.L., GUC D., HINCAL A.A., DELUCA, P.P. - In vitro cytotoxicity of mitoxantrone incorporated albumin microspheres on acute promyelocytic leukemia cells. - J. Microencapsulation, 21, 751-760, 2004.
21. ÇAPAN Y., WOO B.H., GEBREKIDAN S., AHMED S., DELUCA P.P. - Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. - J. Control. Rel., 60, 279-286, 1999.
22. HANSEN M.B., NIELSEN S.E., BERG K. - Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. - J. Immunol. Methods, 119, 203-210, 1989.
23. THANOO B.C., SUNNY M.C., JAYAKRISHNAN A. - Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. - J. Pharm. Pharmacol., 44, 283-286, 1992.
24. JAMEELA S.R., JAYAKRISHNAN A. - Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. - Biomaterials, 16, 769-775, 1995.
25. LATHA M.S., RATHINAM K., MOHANAN P.V., JAYAKRISHNAN A. - Bioavailability of the ophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration. - J. Control. Rel., 34, 1-7, 1995.
26. JAMEELA S.R., KUMARY T.V., LAL A.V., JAYAKRISHNAN A. - Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. - J. Control. Rel., 52, 17-24, 1998.
27. BURGER J.J., TOMLINSON E., MULDER E.M.A., MCVIE J.G. - Albumin microspheres for intra-arterial tumor targeting. I. pharmaceutical aspects. - Int. J. Pharm., 23, 333-344, 1985.
28. BAMBA M., PUISIEUX F., MARTY J.P., CARSTENSEN J.T. - Release mechanism in gel forming sustained release preparations. - Int. J. Pharm., 2, 307-315, 1979.
29. WOLFF J.E., TRILLING T., MOLENKAMP G. - Chemosensitivity of glioma cells in vitro: a meta analysis. - J. Cancer Res. Clin. Oncol., 125, 481-486, 1999.
30. LEWEKE F., DAMIAN M.S., SCHINDLER C., SCHACHENMAYR W. - Multidrug resistance in glioblastoma. - Pathol. Res. Pract., 194, 149-155, 1998.
31. BIRCHALL L.A., BAILEY N.P., BLACKLEDGE G.R.P. - An overview of mitozantrone. - Brit. J. Clin. Pharm., 45, 208-211, 1991.
32. CEBERG C.P., BRUN A., KAHL S.B., KOO M.S., PERSSON B.R.R., SALFORD L.G. - A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin(BOPP) and sulfhydryl boron hydride(BSH) in the RG2 rat glioma model. - J. Neurosurg., 83, 86-92, 1995.